1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Onychomycosis Treatment Market
2.3. Global Onychomycosis Treatment Market, By Treatment Type, 2025 (US$ Million)
2.4. Global Onychomycosis Treatment Market, By Disease Type, 2025 (US$ Million)
2.5. Global Onychomycosis Treatment Market, By Gender, 2025 (US$ Million)
2.6. Global Onychomycosis Treatment Market, By End Use, 2025 (US$ Million)
2.7. Global Onychomycosis Treatment Market, By Geography, 2025 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2025
3. Onychomycosis Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Onychomycosis Treatment Market Vendors
3.2. Strategies Adopted by Onychomycosis Treatment Market Vendors
4. Onychomycosis Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Onychomycosis Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Drugs
5.3.1.1. Oral antifungal drugs
5.3.1.2. Topical antifungal drugs
5.3.2. Laser and photodynamic therapy
5.3.3. Surgery
6. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Distal subungual onychomycosis
6.3.2. Proximal subungual onychomycosis
6.3.3. White superficial onychomycosis
6.3.4. Other disease types
7. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Male
7.3.2. Female
8. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Hospitals
8.3.2. Dermatology clinics
8.3.3. Homecare settings
8.3.4. Ambulatory surgical centers
9. North America Onychomycosis Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.3. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
9.4. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
9.5. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
9.6. Onychomycosis Treatment Market: By Region, 2024-2034, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
9.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
9.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
9.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
9.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
9.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
9.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
9.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10. UK and European Union Onychomycosis Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.3. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.4. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.5. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6. Onychomycosis Treatment Market: By Region, 2024-2034, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.4.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.4.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.4.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6.1.5. France
10.6.1.5.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.5.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.5.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.5.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
10.6.1.6.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
10.6.1.6.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
10.6.1.6.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11. Asia Pacific Onychomycosis Treatment Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.3. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.4. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.5. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6. Onychomycosis Treatment Market: By Region, 2024-2034, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6.1.3. India
11.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.4.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.4.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.4.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.5.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.5.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.5.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
11.6.1.6.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
11.6.1.6.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
11.6.1.6.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
12. Latin America Onychomycosis Treatment Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.3. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
12.4. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
12.5. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
12.6. Onychomycosis Treatment Market: By Region, 2024-2034, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
12.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
12.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
12.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
12.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
12.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
12.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
12.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
13. Middle East and Africa Onychomycosis Treatment Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.3. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
13.4. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
13.5. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
13.6. Onychomycosis Treatment Market: By Region, 2024-2034, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
13.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
13.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
13.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
13.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2024-2034, USD (Million)
13.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2024-2034, USD (Million)
13.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2024-2034, USD (Million)
13.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2024-2034, USD (Million)
14. Company Profile
14.1. Azilda Family Foot Care (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. Bausch Health Sciences
14.3. Dr. Reddy's Laboratories
14.4. Galderma Laboratories
14.5. GlaxoSmithKline
14.6. Johnson & Johnson Services
14.7. Kaken Pharmaceuticals
14.8. Merz Pharma
14.9. Moberg Pharma
14.10. Novartis
14.11. Pfizer
14.12. Skin Logic Aesthetics
14.13. South Charlotte General and Vascular Surgery
14.14. Other Notable Players
